Results 21 to 30 of about 197,741 (365)

Current evidence on efficacy of COVID‐19 booster dose vaccination against the Omicron variant: A systematic review

open access: yesJournal of Medical Virology, 2022
Coronavirus disease 2019 (COVID‐19) is an ongoing pandemic, which affected around 45 million confirmed cases of COVID‐19, including more than 6 million deaths.
Santenna Chenchula   +3 more
semanticscholar   +1 more source

How Does the Public Receive Information about Vaccines during the COVID-19 Pandemic? A Nationwide Cross-Sectional Study in Spain

open access: yesSocieties, 2023
Spain has been one of the most severely impacted countries by COVID-19. Vaccination against COVID-19 is one of the most successful preventive strategies.
Daniel Catalan-Matamoros   +1 more
doaj   +1 more source

Effectiveness and waning of protection with the BNT162b2 vaccine against the SARS-CoV-2 Delta variant in immunocompromised individuals

open access: yesFrontiers in Immunology, 2023
IntroductionIn Hungary, the HUN-VE 3 study determined the comparative effectiveness of various primary and booster vaccination strategies during the Delta COVID-19 wave.
Zoltán Szekanecz   +9 more
doaj   +1 more source

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

open access: yesThe Lancet, 2021
Summary Background Few data exist on the comparative safety and immunogenicity of different COVID-19 vaccines given as a third (booster) dose.
A. Munro   +306 more
semanticscholar   +1 more source

mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant

open access: yesNature Medicine, 2021
The Omicron variant of SARS-CoV-2 is causing a rapid increase in infections across the globe. This new variant of concern carries an unusually high number of mutations in key epitopes of neutralizing antibodies on the viral spike glycoprotein, suggesting
H. Gruell   +8 more
semanticscholar   +1 more source

Evidence of exhausted lymphocytes after the third anti-SARS-CoV-2 vaccine dose in cancer patients

open access: yesFrontiers in Oncology, 2022
IntroductionEvidence is scant regarding the long-term humoral and cellular responses Q7 triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccines in cancer patients after repeated booster doses.
Javier David Benitez Fuentes   +19 more
doaj   +1 more source

Effect of Stapler Booster on Post-operative Air Leakage in the Surgical Treatment of Bullous Lung Disease [PDF]

open access: yes, 2021
Objective:Prolonged air leakage is a major complication of operations for bullous lung disease. This study aimed to investigate the effect of using buttressed staple lines on post-operative air leakage in patients who underwent bullous lung disease (BLD)
Ömer Giray İNTEPE   +3 more
core   +1 more source

Studies on composite solid propellant with tri-modal ammonium perchlorate containing an ultrafine fraction

open access: yesDefence Technology, 2017
Composite solid propellant is prepared using tri-modal Ammonium perchlorate (AP) containing coarse, fine and ultrafine fractions of AP with average particle size (APS) 340, 40 and 5 μm respectively, in various compositions and their rheological ...
K.V. Suresh Babu   +4 more
doaj   +1 more source

Awareness and Acceptance for COVID-19 Booster Dose Vaccination among Residents of Saudi Arabia: Findings of a Cross-Sectional Study

open access: yesVaccines, 2023
Background: In the global effort to combat SARS CoV2 infection, adoption of the vaccination has been an essential component. The goal of this research was to determine the quality of web-based information gathered during COVID-19 and participants ...
Mohammad Shakil Ahmad   +11 more
doaj   +1 more source

Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study

open access: yesLancet. Infectious Diseases (Print), 2023
Background In late 2022, the SARS-CoV-2 omicron (B.1.1.529) BA.5 sublineage accounted for most of the sequenced viral genomes worldwide. Bivalent mRNA vaccines contain an ancestral SARS-CoV-2 strain component plus an updated component of the omicron BA.4
R. Arbel   +9 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy